CD14 and atherosclerosis: Therefore, it is likely that the chronic low-grade inflammatory condition with abundance of the pro-inflammatory monocyte phenotype in patients with femoral atherosclerosis together with higher levels of LTB4 may further contribute to a down-regulation of the BLTR1 and thus be in line with our findings of reduced BLTR1+ MVs and CD14+ MVs.